当可卡因与多巴胺载体结合时,可卡因会被质子化吗?
Marie L Gram1, Julia M Warren1, Emilie L Madsen1
1Department of Chemistry, Faculty of Science, University of Copenhagen, Copenhagen DK-2100, Denmark.
JACS Au
|March 28, 2025
概括
可卡因以其质子化形式与人类多巴胺转运体 (DAT) 结合,解决了长期存在的争议. 这种质子化解释了不同可卡因类型对DAT的不同亲和力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 生物化学 生物化学
背景情况:
- 关于可卡因与人类多巴胺转运体 (DAT) 的结合一直在争论,特别是关于其质子化状态.
- 强大的DAT抑制剂通常是强的胺基,但一些中性可卡因类似物表现出高亲和力,产生冲突的结构-活性关系.
研究的目的:
- 调查可卡因是否以其质子形式与人类多巴胺载体 (DAT) 结合.
- 阐明可卡因类型对DAT的不同亲和力背后的机制.
主要方法:
- 使用一种光可卡因类似物,其pKa比可卡因低.
- 在涉及可卡因结合的DAT中确定了阿斯巴酸盐残留物的pKa.
主要成果:
- 发现光可卡因类似物在DAT结合部位内被质子化.
- 在DAT中确定了关键酸残留物的pKa.
结论:
- 预计可卡因以其质子化形式与DAT结合.
- 确定DAT酸盐残留物的pKa解释了可卡因类似物观察到的结构活性数据,解决了以前的矛盾.
相关概念视频
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...


